Pär Matsson

3.9k total citations
36 papers, 2.8k citations indexed

About

Pär Matsson is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Pär Matsson has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Pär Matsson's work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Pär Matsson is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Pär Matsson collaborates with scholars based in Sweden, United States and United Kingdom. Pär Matsson's co-authors include Per Artursson, Jan Kihlberg, Christel A. S. Bergström, Ulf Norinder, Jenny M. Pedersen, Björn Over, B.C. Doak, André Mateus, Kathleen M. Giacomini and Yasuto Kido and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Pär Matsson

36 papers receiving 2.7k citations

Peers

Countries citing papers authored by Pär Matsson

Since Specialization

Citations

This map shows the geographic impact of Pär Matsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Matsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Matsson more than expected).

Fields of papers citing papers by Pär Matsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Matsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Matsson. The network helps show where Pär Matsson may publish in the future.

Co-authorship network of co-authors of Pär Matsson

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Matsson. A scholar is included among the top collaborators of Pär Matsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Matsson. Pär Matsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges in Permeability Assessment for Oral Drug Product Development 2023 ·Pharmaceutics ·Mirko Koziolek, Patrick Augustijns, (unknown), Rodrigo Cristofoletti, David Dahlgren, Janneke Keemink, Pär Matsson, Fiona McCartney, Marco Metzger, Mario Mezler, (unknown), James E. Polli, Maria Vertzoni, Werner Weitschies, Jennifer Dressman	12
2	High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3 2022 ·Pharmaceutical Research ·Eugene C. Chen, Pär Matsson, (unknown), (unknown), (unknown), Sook Wah Yee, Per Artursson, Kathleen M. Giacomini	15
3	Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3 2020 ·Journal of Pharmaceutical Sciences ·Ling Zou, Pär Matsson, Adrian Stecuła, Huy Ngo, Arik A. Zur, Kathleen M. Giacomini	17
4	A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (fu,cell) 2019 ·Pharmaceutical Research ·(unknown), (unknown), Hinnerk Boriss, Pär Matsson, Per Artursson	7
5	Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches 2018 ·Clinical Pharmacology & Therapeutics ·Yingying Guo, Xiaoyan Chu, Neil Parrott, Kim L. R. Brouwer, Vicky Hsu, Swati Nagar, Pär Matsson, Pradeep Sharma, Jan Snoeys, Yuichi Sugiyama, Daniel Tatosian, Jashvant D. Unadkat, Shiew‐Mei Huang, Aleksandra Galetin	88
6	Intracellular drug bioavailability: a new predictor of system dependent drug disposition 2017 ·Scientific Reports ·André Mateus, (unknown), Christine Wegler, Maria Karlgren, Pär Matsson, Per Artursson	59
7	Cell permeability beyond the rule of 5 2016 ·Advanced Drug Delivery Reviews ·Pär Matsson, B.C. Doak, Björn Over, Jan Kihlberg	220
8	The Proteome of Filter-Grown Caco-2 Cells With a Focus on Proteins Involved in Drug Disposition 2016 ·Journal of Pharmaceutical Sciences ·Magnus Ölander, Jacek R. Wiśniewski, Pär Matsson, Patrik Lundquist, Per Artursson	62
9	Structural and conformational determinants of macrocycle cell permeability 2016 ·Nature Chemical Biology ·Björn Over, Pär Matsson, Christian Tyrchan, Per Artursson, B.C. Doak, Michael A. Foley, Constanze Hilgendorf, Stephen Johnston, Maurice D. Lee, Richard J. Lewis, Patrick McCarren, Giovanni Muncipinto, Ulf Norinder, Matthew W. D. Perry, Jeremy R. Duvall, Jan Kihlberg	160
10	Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9 2016 ·Journal of Pharmaceutical Sciences ·(unknown), Maria Karlgren, Maria Backlund, (unknown), Fabienne Z. Gaugaz, Pär Matsson, Per Artursson	55
11	Quantifying the impact of transporters on cellular drug permeability 2015 ·Trends in Pharmacological Sciences ·Pär Matsson, Luca A. Fenu, Patrik Lundquist, Jacek R. Wiśniewski, Manfred Kansy, Per Artursson	26
12	Computational modeling to predict the functions and impact of drug transporters 2015 ·In Silico Pharmacology ·Pär Matsson, Christel A. S. Bergström	18
13	Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11) 2013 ·Toxicological Sciences ·Jenny M. Pedersen, Pär Matsson, Christel A. S. Bergström, Janet Hoogstraate, Agneta Norén, Edward L. LeCluyse, Per Artursson	114
14	Computational Prospecting for Drug–Transporter Interactions 2013 ·Clinical Pharmacology & Therapeutics ·Pär Matsson, Per Artursson	4
15	Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping 2011 ·The Pharmacogenomics Journal ·Pär Matsson, Sook Wah Yee, Svetlana Markova, Karyn Morrissey, Gregory D. Jenkins, Jim W. Xuan, Eric Jorgenson, Deanna L. Kroetz, Kathleen M. Giacomini	15
16	Comparison of human solute carriers 2010 ·Protein Science ·Avner Schlessinger, Pär Matsson, James E. Shima, Ursula Pieper, Sook Wah Yee, Libusha Kelly, Leonard Apeltsin, Robert M. Stroud, Thomas E. Ferrin, Kathleen M. Giacomini, Andrej Săli	87
17	Understanding polymer–lipid solid dispersions—The properties of incorporated lipids govern the crystallisation behaviour of PEG 2009 ·International Journal of Pharmaceutics ·(unknown), Pär Matsson, Denny Mahlin	18
18	Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs 2009 ·Pharmaceutical Research ·Pär Matsson, Jenny M. Pedersen, Ulf Norinder, Christel A. S. Bergström, Per Artursson	251
19	A Global Drug Inhibition Pattern for the Human ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (ABCG2) 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Pär Matsson, Gunilla Englund, Gustav Ahlin, Christel A. S. Bergström, Ulf Norinder, Per Artursson	94
20	Conditioned Media from Cultured Blood Cells of Atopic Individuals Can Induce Differentiation in the Human Basophilic Leukemia Cell Line KU812 1989 ·International Archives of Allergy and Immunology ·Pär Matsson, Ingrid Almlöf, (unknown), S. Ahlstedt	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact